Print Friendly, PDF & Email

Public Comment on Social Security Disability

Through an email from NORD, the CSRF learned that public comment was being invited on possible changes to determination of Social Security Disability. The desire of the SSA is to handle more disability claims before they get to the time consuming hearing level. The CSRF continually hears from members who are pursuing disability and almost always, they need to go to the hearing level, primarily because no one in SSI understands the disorder. Thus, we had a rare opportunity to comment and perhaps get Cushing’s higher visibility. Working with our Medical Advisory Board, the CSRF drafted the response printed below. CSRF also sent a copy of our response to Abby Meyers, President of NORD. Abby commented, “All of us believe this is a wonderful opportunity for us to fix the disability system for people with unfamiliar diagnoses. The best way to do that is to encourage our medical advisors to develop sensible parameters for each disorder. So the simple fact that you submitted comments puts Cushing’s disease on SSA’s priority list. Let’s hope they invite you to submit more information about Cushing’s or invite you to one of their public meetings.”

The Cushing’s Support and Research Foundation
60 Robbins Rd., #12, Plymouth, MA 02360
September 29, 2007

To Whom It May Concern:

This communication is being written in response to the request for comments in the Federal Register on improving the SSI disability process. The Cushing’s Support and Research Foundation (CSRF) is a non-profit organization providing support and information to patients and families affected by endogenous Cushing’s. The CSRF has a Medical Advisory Board comprised of expert endocrinologists and neurosurgeons and is an Associate Member of NORD and The Endocrine Society. The CSRF often hears from patients who have been denied SSI and are preparing for their disability hearing. Most of these patients express frustration about how little the SSA understands about Cushing’s. The symptoms of Cushing’s and the severity of symptoms vary widely between patients. Thus, we are not certain that a list of specific impairments or symptoms and their associated severity can be developed to ease the disability process. Our concern in developing such a specific list, is that patients that have variations in the symptoms would be denied because they do not “fit the mold”. Not all patients with Cushing’s would qualify for disability. Thus, our goal in writing this response is to provide some general thoughts on Cushing’s as it relates to disability, to provide some general information on Cushing’s, to identify some of the symptoms and severity that can contribute to disability, and to provide a list of “expert” physicians who given adequate time, might be able to generate some specific impairments and associated severity.


Endogenous Cushing’s is defined as a Rare Disorder and has an estimated incidence rate of 5-25 per million of population/year. Since Cushing’s is a Rare Disorder, many primary care physicians and even endocrinologists are unfamiliar with the diagnosis, treatment and recovery required. Many patients with Cushing’s go undiagnosed for many years prior to receiving a correct diagnosis, simply because it is a rare disorder and symptoms overlap ailments that are common in the general population. Once diagnosed, many patients are faced with requesting support for disability from physicians who have little knowledge of the disorder. Thus, we have 2 thoughts:

  1. Perhaps a different disability procedure for Rare Disorders that utilizes expert physicians would be useful.
  2. Because Cushing’s is difficult to diagnose and can lead to disability, we are certain that there are undiagnosed cases among those currently on disability. For example, recent studies have found that approximately 5% of poorly controlled diabetics actually have Cushing’s. Other potential high-risk populations such as those with osteoporosis, high blood pressure and obesity are currently under study. A study is also underway to determine if certain combinations of clinical symptoms might be useful in identifying patients who should be tested. The SSA could provide valuable assistance to patients looking for a diagnosis if records could be screened for the possibility of Cushing’s during the disability application process. Perhaps personnel doing medical evaluations for the SSA could be further educated on Cushing’s. We are certain that a panel of experts could identify subsets of patients that should be tested for Cushing’s.


It is not necessary to provide a detailed description of Cushing’s in these comments. More information can be obtained from the medical literature, our web site at, and NIH Publication #02-3007, June, 2002, which can also be found at – Understanding Cushing’s – Fact Sheet. Generally, endogenous Cushing’s is caused by exposure to too much cortisol due to a pituitary tumor, or an adrenal or ectopic tumor.


A list of symptoms can be obtained from a recent publication – Long-Term Impaired Quality of Life in Cushing’s Syndrome despite Initial Improvement after Surgical Remission, JCEM 91(2):447-453. If Cushing’s progresses beyond a mild form, most all patients complain of weight gain, a redistribution of fat to the face and the upper back (buffalo hump) resulting in extreme changes in their appearance. In the majority of cases, Cushing’s begins with mild symptoms and if left undiagnosed and untreated, both physical and mental symptoms progress to severe.

During Cushing’s, symptoms that can lead to disability, include fatigue, sleep disorders, depression and a multitude of associated mental changes such as mood swings, tearfulness, anxiety, etc. Cushing’s can also dramatically influence a person’s ability to concentrate and remember things, thus patients can have problems dealing with everyday life due to cognitive difficulties. Physically, patients can become extremely weak due to muscle atrophy and have difficulty walking short distances, rising from a chair or climbing any stairs, which can severely limit daily activities. Often, a combination of physical and mental symptoms contribute to disability.

After treatment of Cushing’s, patients require a period of time on replacement medication before their own HPA axis begins to function appropriately. Most experienced endocrinologists and neurosurgeons put the recovery time frame somewhere between 1 year and 18 months. Some patients have little difficulty during the recovery time period, while others have severe fatigue, weakness, pain and depression that can dramatically influence daily functioning. While most patients do improve during this time frame, some struggle with attempting to discontinue replacement medications for much longer. At the present time, it is not known why some patients recover much easier than others, but perhaps it could be associated with the length of time someone had Cushing’s and perhaps age plays a role.

While it is well demonstrated that following appropriate treatment, Cushing’s patients do improve, it is also widely recognized that not all symptoms resolve completely or may required extended periods of time. This is true for bone strength, mental function due to brain atrophy, diabetes, hypertension and muscle weakness, all of which can be objectively measured. In a survey of CSRF members done in 2002 (not published) only 36% of Cushing’s patients reported no residual symptoms, with the most common residual symptoms being fatigue, weakness, and mental/emotional issues. The severity of the remaining symptoms will determine if disability continues.

The above pertains to those patients who are successfully treated. In cases where the pituitary tumor cannot be surgically removed or an ectopic tumor cannot be identified, patients are faced with longer periods of time to endure symptoms.


The CSRF supports the consultation of expert physicians during all phases of Cushing’s. Those physicians listed on our Medical Advisory Board are known to be excellent in their field and well respected by their peers. There are also additional expert physicians listed at – Cushing’s Doctors. A number of our Medical Advisory Board physicians have provided input to this document and particularly agree that a different disability procedure for Rare Disorders that utilizes expert physicians would be helpful.

Thank you in advance for your consideration. Please let us know if we can be of further help.


Louise Pace – President, CSRF

Karen Campbell – Director, CSRF

Jennifer Kirkland, PhD
CSRF Member

Dr. David Cook, MD
Endocrinology & Diabetes
Pituitary Diseases Clinic
Oregon Health Sciences University
Portland, Oregon

Dr. Edward R. Laws, MD, FACS
Department of Neurosurgery
Brigham and Women’s
Boston, MA

Dr. Anne Klibanski, M.D.
Professor of Medicine
Harvard Medical School
Chief, Neuroendocrine Unit
Massachusetts General Hospital
Boston, MA

Dr. Martin Weiss, MD
Chief, Department of Neurosurgery
University of Southern California
School of Medicine
Los Angeles, CA

Sorry, comments are closed for this post.